Depressive symptoms and short telomere length are associated with increased mortality in bladder cancer patients

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 2, 2015, Pages 336-343

  Lin, Jie ^a   Blalock, Janice A ^a   Chen, Meng ^a   Ye, Yuanqing ^a   Gu, Jian ^a   Cohen, Lorenzo ^a   Cinciripini, Paul M ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; DEPRESSION; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SURVIVAL TIME; TELOMERE HOMEOSTASIS; AGED; BLADDER TUMOR; BLOOD; CAUSE OF DEATH; DEPRESSIVE DISORDER; MORTALITY; PROSPECTIVE STUDY; TELOMERE SHORTENING;

BIOLOGICAL MARKER;

AGED; BIOMARKERS; CAUSE OF DEATH; DEPRESSIVE DISORDER; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TELOMERE SHORTENING; URINARY BLADDER NEOPLASMS;

EID: 84922690332     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-14-0992     Document Type: Article

References (57)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012;62:10-29.
2. Kaufman DS, Shipley WU, Feldman AS. Bladder cancer. Lancet 2009;374: 239-49.
3. Porta N, Calle ML, Malats N, Gomez G. A dynamic model for the risk of bladder cancer progression. Stat Med 2012;31:287-300.
4. Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol 2006;24:3967-72.
5. Cuijpers P, Smit F. Excess mortality in depression: a meta-analysis of community studies. J Affect Disord 2002;72:227-36.
6. Barth J, Schumacher M, Herrmann-Lingen C. Depression asa risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psycho-som Med 2004;66:802-13.
7. Pan A, Lucas M, Sun Q, van Dam RM, Franco OH, Willett WC, et al. Increased mortality risk in women with depression and diabetes mellitus. Arch Gen Psychiatry 2011;68:42-50.
8. Pinquart M, Duberstein PR. Depression and cancer mortality: a meta-analysis. Psychol Med 2010;40:1797-810.
9. Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: a meta-analysis. Cancer 2009;115:5349-61.
10. Giese-Davis J, Collie K, Rancourt KM, Neri E, Kraemer HC, Spiegel D. Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: a secondary analysis. J Clin Oncol 2011;29:413-20.
11. Hjerl K, Andersen EW, Keiding N, Mouridsen HT, Mortensen PB, Jorgensen T. Depression as a prognostic factor for breast cancer mortality. Psychoso-matics 2003;44:24-30.
12. Wolkowitz OM, Epel ES, Reus VI, Mellon SH. Depression gets old fast: do stress and depression accelerate cell aging? Depress Anxiety 2010;27: 327-38.
13. DePinho RA, Wong KK. The age of cancer: telomeres, checkpoints, and longevity. J Clin Invest 2003;111:S9-14.
14. Elvsashagen T, Vera E, Boen E, Bratlie J, Andreassen OA, Josefsen D, et al. The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder. J Affect Disord 2011;135:43-50.
15. Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, et al. Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 2006; 60:432-5.
16. Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y, et al. Leukocyte telomere length in major depression: correlations with chronic-ity, inflammation and oxidative stress-preliminary findings. PLoS ONE 2011;6:e17837.
17. Ludlow AT, Roth SM. Physical activity and telomere biology: exploring the link with aging-related disease prevention. J Aging Res 2011;2011:790378.
18. Ma H, Zhou Z, Wei S, Liu Z, Pooley KA, Dunning AM, et al. Shortened telomere length is associated with increased risk of cancer: a meta-analysis. PLoS ONE 2011;6:e20466.
19. Willeit P, Willeit J, Mayr A, Weger S, Oberhollenzer F, Brandstatter A, et al. Telomere length and risk of incident cancer and cancer mortality. JAMA 2010;304:69-75.
20. Willeit P, Willeit J, Kloss-Brandstatter A, Kronenberg F, Kiechl S. Fifteen-year follow-up of association between telomere length and incident cancer and cancer mortality. JAMA 2011;306:42-4.
21. Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, et al. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol 2007;25:4974-81.
22. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
23. Husaini BA, Neff JA, Harrington JB, Hughes MD, Stone RH. Depression in rural communities: Validating the CES-D scale. J Community Psychol 1980;8:20-7.
24. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for Axis I DSM-IV-TR Disorders-Patient Edition (with psychotic screen). 2 ed. New York, NY: New York Psychiatric Institute; 2001.
25. Chen M, Hildebrandt MA, Clague J, Kamat AM, Picornell A, Chang J, et al. Genetic variations in the sonic hedgehog pathway affect clinical outcomes in non-muscle-invasive bladder cancer. Cancer Prev Res 2010;3:1235-45.
26. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res 2002;30:e47.
27. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: Conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82.
28. Spiegel D, Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 2003;54:269-82.
29. Baillargeon J, Kuo YF, Lin YL, Raji MA, Singh A, Goodwin JS. Effect of mental disorders on diagnosis, treatment, and survival of older adults with colon cancer. J Am Geriatr Soc 2011;59:1268-73.
30. Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc 2004;52:106-11.
31. da Silva MA, Singh-Manoux A, Shipley MJ, Vahtera J, Brunner EJ, Ferrie JE, et al. Sleep duration and sleep disturbances partly explain the association betweendepressive symptoms and cardiovascular mortality: the Whitehall II cohort study. J Sleep Res 2014;23:94-7.
32. Lawrence D, Kisely S, Pais J. The epidemiologyof excess mortality in people with mental illness. Can J Psychiatry 2010;55:752-60.
33. Reiche EM, Nunes SO, Morimoto HK. Stress, depression, the immune system, and cancer. Lancet Oncol 2004;5:617-25.
34. Lutgendorf SK, Sood AK, Antoni MH. Host factors and cancer progression: biobehavioral signaling pathways and interventions. J Clin Oncol 2010; 28:4094-9.
35. Reiche EM, Morimoto HK, Nunes SM. Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry 2005;17:515-27.
36. Shi M, Liu D, Yang Z, Guo N. Central and peripheral nervous systems: master controllers in cancer metastasis. Cancer Metastasis Rev 2013;32: 603-21.
37. Svenson U, Nordfjall K, Stegmayr B, Manjer J, Nilsson P, Tavelin B, et al. Breast cancer survival is associated with telomere length in peripheral blood cells. Cancer Res 2008;68:3618-23.
38. Svenson U, Ljungberg B, Roos G. Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Res 2009;69: 2896-901.
39. Hartmann N, Boehner M, Groenen F, Kalb R. Telomere length of patients with major depression is shortened but independent from therapy and severity of the disease. Depress Anxiety 2010;27:1111-6.
40. Shaffer JA, Epel E, Kang MS, Ye S, Schwartz JE, Davidson KW, et al. Depressive symptoms are not associated with leukocyte telomere length: findings from the Nova Scotia Health Survey (NSHS95), a population-based study. PLoS ONE 2012;7:e48318.
41. Wikgren M, Maripuu M, Karlsson T, Nordfjall K, Bergdahl J, Hultdin J, et al. Short telomeres in depression and the general population are associated with a hypocortisolemic state. Biol Psychiatry 2012;71:294-300.
42. Kiecolt-Glaser JK, Gouin JP, Weng NP, Malarkey WB, Beversdorf DQ, Glaser R. Childhood adversity heightens the impact of later-life caregiving stress on telomere length and inflammation. Psychosom Med 2011;73: 16-22.
43. Shalev I, Moffitt TE, Sugden K, Williams B, Houts RM, Danese A, et al. Exposure to violence during childhood is associated with telomere erosion from 5 to 10 years of age: a longitudinal study. Mol Psychiatry 2013;18: 576-81.
44. Surtees PG, Wainwright NW, Pooley KA, Luben RN, Khaw KT, Easton DF, et al. Life stress, emotional health, and mean telomere length in the European Prospective Investigation into Cancer (EPIC)-Norfolk population study. J Gerontol A Biol Sci Med Sci 2011;66:1152-62.
45. Rossi D, Lobetti BC, Genuardi E, Monitillo L, Drandi D, Cerri M, et al. Telomere length is an independent predictor of survival, treatment requirement and Richter's syndrome transformation in chronic lymphocytic leukemia. Leukemia 2009;23:1062-72.
46. Hoxha M, Dioni L, Bonzini M, Pesatori AC, Fustinoni S, Cavallo D, et al. Association between leukocyte telomere shortening and exposure to traffic pollution: a cross-sectional study on traffic officers and indoor office workers. Environ Health 2009;8:41.
47. Valdes AM, Andrew T, Gardner JP, Kimura M, Oelsner E, Cherkas LF, et al. Obesity, cigarette smoking, and telomere length in women. Lancet 2005;366:662-4.
48. Damjanovic AK, Yang Y, Glaser R, Kiecolt-Glaser JK, Nguyen H, Laskowski B, et al. Accelerated telomere erosion is associated with adeclining immune function of caregivers of Alzheimer's disease patients. J Immunol 2007; 179:4249-54.
49. Ornish D, Lin J, Daubenmier J, Weidner G, Epel E, Kemp C, et al. Increased telomerase activity and comprehensive lifestyle changes: a pilot study. Lancet Oncol 2008;9:1048-57.
50. Ornish D, Lin J, Chan JM, Epel E, Kemp C, Weidner G, et al. Effect of comprehensive lifestyle changes on telomerase activity and telo-mere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study. Lancet Oncol 2013;14: 1112-20.
51. Youssef RF, Lotan Y. Predictors of outcome of non-muscle-invasive and muscle-invasive bladder cancer. Scientific World Journal 2011;11:369-81.
52. Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, et al. The influence of bio-behavioural factors on tumour biology: pathways and mechanisms. Nat Rev Cancer 2006;6:240-8.
53. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care 2003;41:1284-92.
54. Mohr DC, Hart SL, Julian L, Tasch ES. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult Scler 2007;13:215-9.
55. Ryan DA, Gallagher P, Wright S, Cassidy EM. Sensitivity and specificity of the distress thermometer and a two-item depression screen (patient health questionnaire-2) with àhelp' question for psychological distress and psychiatric morbidity in patients with advanced cancer. Psychooncology 2012;21:1275-84.
56. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997;12:439-45.
57. Verhoeven JE, Revesz D, Epel ES, Lin J, Wolkwitz OM, Penninx BW. Major depressive disorder and accelerated cellular aging: results from a large psychiatric cohort study. Mol Psychiatry 2014;19:895-901.